tirzepatide 2023 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Not all GLP-1s are created

Delayed gastric emptying could affect the timing and extent of levothyroxine absorption

Endomyocardial thrombus formation

SculptCare operates as a supplier of research compounds and related products

The extra weeks invested in microdosing translate into a smoother experience at therapeutic doses, better adherence to the protocol long-term, and potentially better outcomes

Instead, contact your healthcare provider or pharmacist for guidance on next best steps

The FDA has issued multiple warning letters to Empower over the past several years, documenting concerns about sterile compounding practices, contamination control, and quality assurance procedures